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Abstract
Atomic force microscopy (AFM) was used to study the morphological changes of two Gram-
negative pathogens, Pseudomonas aeruginosa and Escherichia coli, after exposure to nitric oxide
(NO). The time-dependent effects of NO released from a xerogel coating and the concentration-
dependent effects rendered by a small-molecule that releases NO in a bolus were examined and
compared. Bacteria exhibited irregular and degraded exteriors. With NO-releasing surfaces, an
increase in surface debris and disorganized adhesion patterns were observed compared to controls.
Analysis of cell surface topography revealed that increasing membrane roughness correlated with
higher doses of NO. At a lower total dose, NO delivered via a bolus resulted in greater membrane
roughness than NO released from a surface via a sustained flux. At sub-inhibitory levels, treatment
with amoxicillin, an antibiotic known to compromise the integrity of the cell wall, led to
morphologies resembling those resulting from NO treatment. Our observations indicate that cell
envelope deterioration is a visible consequence of NO-exposure for both Gram-negative species
studied.
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1. Introduction
Nitric oxide (NO) is a highly reactive diatomic radical endogenously produced by the
enzyme-catalyzed oxidation of L-arginine to L-citrulline. It has been implicated as a
mediator in multiple physiological processes, ranging from regulatory roles in the
cardiovascular and nervous system to the inducible host response to infection.(1,2) Various
therapeutic properties attributed to NO, including tumor cytotoxicity,(3,4) antimicrobial
activity, and improved wound healing and tissue integration at implant sites,(5) may prove
beneficial in a number of pharmacological applications.(6,7) Due to its reactivity, diverse
regulatory roles, and short half-life in blood (< 1 sec),(8) the ability to target therapeutic NO
delivery locally is critical. Nitric oxide donating compounds, such as N-
diazeniumdiolates(6) and S-nitrosothiols,(9,10) decompose to release NO and hence serve as
vehicles for its storage and transport. A number of materials, including nanoparticles,(11,12)
films and coatings,(13,14) and small molecules,(15,16) have employed NO-donor chemistry
with varied physicochemical and NO-release properties.
The role of NO in the innate immune response is a conserved feature through a wide range
of species, from Drosophila to human.(17) In mammals, macrophages and other immune
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cells produce NO in response to invading pathogens.(18) The antimicrobial properties of NO
may be elicited by direct modification of biomacromolecules or by formation of reactive
nitrogen species (RNS) via reaction with oxygen (O2) or superoxide (O2−).(19) These RNS
may render nitrosative stress by the formation of compounds such as dinitrogen trioxide
(N2O3) and oxidative stress via the formation of peroxynitrite (ONOO−).(19-22) The
spectrum of potential bactericidal mechanisms is thus broad, encompassing DNA damage
resulting from deamination of deoxyribonucleotides, protein damage via numerous potential
reactive sites (e.g. heme groups, thiols, amines) that disrupts normal cellular transport and
metabolism, and membrane damage propagated by radical lipid peroxidation. The local
physiological environment plays a key role in determining the metabolic pathways available
to NO, and it would thus be expected that the bactericidal mechanism(s) of NO produced
endogenously in phagosomal compartments would differ from NO released extracellularly
(e.g., from an implanted biomaterial) as a result of differences in local conditions and
substrates available in the biological milieu.
In vitro, NO has proven a potent antimicrobial agent effective against a range of
microorganisms, including both Gram-negative and Gram-positive bacteria. Gaseous NO
was found to be toxic against a number of pathogenic species, including Candida albicans
and methacillin-resistant Staphylococcus aureus.(23) N-Diazeniumdiolate-modified NO-
releasing surfaces have been shown to reduce initial Pseudomonas aeruginosa adhesion
relative to controls,(24-26) and kill those that do adhere.(27) Nitric oxide release from silica
nanoparticles has been characterized by significant toxicity to bacterial cells with reduced
toxicity to L929 mouse fibroblasts.(28) While the bactericidal effects of NO and NO-
releasing biomaterials have been demonstrated repeatedly, details on the primary targets
resulting in bacterial cytotoxicity and the corresponding cellular effects of NO on microbial
species remain speculative.
Morphological analyses of bacteria aid in understanding mechanisms of antibiotic action by
allowing visualization of changes in the appearance of the microbe undergone subsequent to
treatment. While electron microscopy has been employed toward this end for decades,
(29-31) atomic force microscopy (AFM) has been used with increasing frequency.(32-37)
As a surface characterization tool, AFM is ideal for morphological studies of surface-
adhered bacteria as it allows cells to be imaged in situ with high resolution without requiring
chemical drying, metal coating, or exposure to ultra-high vacuum. An added benefit of AFM
is the flexible and adaptable nature of cantilevers as transducers that allow detection of other
physical (e.g., elasticity) or chemical (e.g., charge distribution) surface parameters
simultaneously with the acquisition of height information. Atomic force microscopy has
been applied to visualizing the antimicrobial action of peptides,(32-34) chitosan,(35)
quantum dots,(36) and the β-lactam antibiotics penicillin and amoxicillin.(37)
Herein, we report a morphological analysis of P. aeruginosa and Escherichia coli after
exposure to NO released from two N-diazeniumdiolate-modified materials: a small molecule
NO-donor derived from proline (PROLI/NO) and a NO donor-modified xerogel surface
coating. The diazeniumdiolate moiety stores two molecules of the antimicrobial agent NO
on each functionalized amine. Exposure to proton sources such as buffer and blood catalyzes
the release of NO. Using topographical surface mapping and nanometer-scale height
resolution, changes in bacteria shape and surface roughness were studied as a function of
exposure time, material, and quantity of NO released.
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2. Materials and methods
2.1 Materials
Ethanol and methanol were purchased from Fisher Scientific (Pittsburgh, PA). Argon, NO,
nitrogen (N2), and a 25.7 ppm gaseous NO standard in N2 were purchased from National
Welders (Raleigh, NC). N-(6-aminohexyl) aminopropyltrimethoxysilane (AHAP3) was
obtained from Gelest (Tullytown, PA). Amoxicillin was obtained from Fluka (Buchs,
Switzerland). Isobutyltrimethoxysilane (BTMOS), L-proline, sodium methoxide, and
dimethylsulfoxide (DMSO) were purchased from Sigma-Aldrich (St. Louis, MO). The
amino- and alkoxysilanes were stored over desiccant. The above chemicals were used
without further purification. Distilled water was purified with a Millipore Milli-Q UV
Gradient A-10 system (Bedford, MA) to a resistivity of 18.2 MΩ cm.
2.2 Cell culture P. aeruginosa
(ATCC #19143) and E. coli (ATCC #53323) were obtained from American Type Culture
Collection (Manassas, VA) and cultured in tryptic soy broth (TSB). Stock cultures were
prepared and stored at −80 °C for subsequent experiments. A 1-mL aliquot from an
overnight culture was inoculated in ~100 mL of TSB and incubated at 37 °C for 3-5 h until
the culture reached mid-exponential log phase as determined from optical density at 600 nm
(OD600 = 0.2 ± 0.1), corresponding to ~108 colony forming units (cfu) mL−1.
2.3 Synthesis of xerogel films
Glass slides were coated with a 40% (v:v total silane content) AHAP3/BTMOS xerogel film
via a 2-step process as described by Marxer et al.(13) Briefly, 120 μl BTMOS was mixed
with 60 μl water, 200 μl ethanol, and 10 μl of 0.5 M HCl for 1 h. Then, 80 μl of AHAP3
was added, and the solution was mixed for an additional hour. Glass slides were cut into
sections (dim. 13 × 17.5 mm), rinsed with ultrapure water and ethanol, dried under a stream
of nitrogen, and cleaned for 30 min in a UV-ozone cleaner (BioForce, Ames, IA). To cast a
film, 40 μl of the sol was pipetted onto clean glass slides, dried for 30 min at ambient
temperature, and cured at 85 °C for 3 d. Control xerogel films were stored in desiccators at
22 °C.
2.4 NO-donor synthesis and characterization
Xerogels were modified to release NO by exposing the films to 5 atm of NO for 72 h as
previously described.(13) The NO chamber was flushed twice with 5 atm Ar to remove
atmospheric impurities (e.g., oxygen, water) prior to introducing NO gas. After 3 d,
unreacted NO was removed by flushing the vessel with Ar.
L-proline was converted to PROLI/NO following a procedure previously reported by
Saavedra, et al.(15) Briefly, 10 g of L-proline was dissolved in 39 mL of 25% sodium
methoxide in methanol. This solution was combined with an additional 20 mL of methanol,
and exposed to NO gas (5 atm) as described above. The resulting PROLI/NO formed as a
white precipitate that was collected via filtration, washed with ether, and vacuum dried. All
NO-releasing materials (i.e., PROLI/NO and xerogels) were stored in vials purged with
nitrogen at −20 °C until use in order to stabilize the NO donor.
A chemiluminescent nitric oxide analyzer (NOA) (Sievers Model 280, Boulder, CO) was
used to measure NO release in real time. A known quantity of the NO-release material was
placed in a flask containing phosphate buffered saline (PBS, pH = 7.4) positioned in a water
bath maintained at 37 °C. The NO generated via diazeniumdiolate decomposition was
carried into the analyzer via a stream of N2 bubbled into the solution at a flow rate of 80 mL
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min−1. The detector was calibrated by a 2-point curve using an atmospheric sample passed
through an NO zero filter and a 25.7 ppm NO standard.
2.5 Bacterial adhesion to control and NO-releasing xerogels
Prior to use, the NO-releasing xerogels were allowed to reach ambient temperature. Control
and NO-releasing films were rinsed briefly with ultrapure water and dried under a stream of
nitrogen immediately prior to bacterial adhesion. After diluting bacterial suspensions in TSB
(1:2 in PBS), a 200-μL aliquot of the solution was beaded directly onto the xerogel surface.
Substrates were covered to reduce evaporation and incubated for either 1 h (in preparation
for treatment in antibiotic solutions) or 2 h (NO-releasing xerogels) at 37 °C to allow for
bacterial adhesion.
2.6 Antimicrobial treatment
For time points exceeding 2 h, NO-releasing xerogels with adhered bacteria were placed in
vials containing 5 mL of PBS and incubated at 37 °C for the remainder of the exposure
period. For treatment with PROLI/NO, the appropriate mass was first weighed into chilled,
dry vials. The correct volume of PBS (~5 mL) was added to obtain the desired
concentration, vortexed briefly, and a control (unmodified) xerogel with adhered, untreated
bacteria was immediately added to the PROLI/NO solution and incubated for 2 h at 37 °C.
Amoxicillin treatment was achieved by preparing a 1 μg mL−1 solution in PBS from a 9.6
mg mL−1 stock solution in DMSO, into which a control xerogel (with adhered bacteria) was
placed and incubated for 2 h at 37 °C. Each xerogel time point and antibiotic concentration
was replicated for each species studied. A detailed description of the substrate rinsing
process is provided below.
2.7 Substrate preparation technique
A gentle-rinse procedure was developed to ensure that adhered cells remained relatively
undisturbed for subsequent treatment and/or imaging experiments. A rinse step was
accomplished by pipetting a single, 300-μL aliquot of the appropriate rinse solution onto the
substrate. Immediately thereafter, the solution was removed with a narrow-tipped pipette in
100-μL increments. Of note, the pipette was only applied to the outer edge of the substrate
to remove residual rinse solution so as not to disturb the surface to be imaged.
For both control and NO-releasing xerogels, excess cell suspension in TSB was removed
from the surface after the adhesion period, followed by five consecutive rinses with PBS to
remove TSB, non-adhered cells, and trace cellular components. If adhered cells were
subsequently treated, the substrate was added to a vial containing the appropriate
concentration of antimicrobial agent in PBS (PROLI/NO, amoxicillin) for 2 h or PBS (40%
AHAP3/BTMOS xerogel time points exceeding 2 h) at 37 °C. The final rinse steps consisted
of 5 washes with ultrapure water to remove antibiotic and/or salts, after which the substrate
was dried using capillary action by placing absorbent paper at the edge of the substrate to
draw excess water off the surface. A thin layer of water remained, which was allowed to
evaporate prior to imaging. hawse have previously shown that the process of drying bacteria
at xerogel surfaces does not affect their viability.(38)
2.8 AFM Imaging
Simultaneous AFM height, amplitude, and phase images were obtained in AC mode on the
air-dried substrates using an Asylum MFP-3D AFM (Santa Barbara, CA). Olympus
AC240TS silicon beam cantilevers (Center Valley, PA) with a spring constant of 2 N m−1
and resonant frequency of 70 kHz were used to image bacteria in air. At least three 20 μm2
survey images were obtained at random locations at an interior region of each substrate.
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Additional images captured control and antibiotic treated cells at greater magnifications.
Images were acquired at a resolution of 512 × 512 pixels and scan speed of 1 Hz. Individual
root-mean-square (rms) roughness of cell membranes was calculated using the MFP-3D
software from 500 and 800 nm2 regions of P. aeruginosa and E. coli, respectively. Images
used for roughness determination were acquired in the central part of a cell and were
flattened by one order to reduce contributions from cell curvature at the edges of the image.
Membrane roughness values were averaged from at least 3 different cells per species, agent,
and dose. Artificial color and light were added to the three-dimensional reconstructions of
height data to aid visualization of image detail.
3. Results and Discussion
3.1 Material characterization and experimental design
Bacterial cells were exposed to two NO-releasing materials that differ in their kinetic release
profiles. A representative NO-release profile and the average integrated dose delivered from
a 40% AHAP3/BTMOS xerogel film as a function of time are provided in Figure 1 and
Table 1, respectively. Nitric oxide is released from these films via a surface flux, increasing
rapidly upon exposure to aqueous solution and reaching a maximum within half an hour.
Thereafter, the NO release gradually reduces to a flux averaging ~50 pmol cm−2 s−1 over 24
h. Hetrick, et al. reported that a total dose of NO between 375 and 425 nmol cm−2 delivered
from 40 % AHAP3/BTMOS xerogels 5 – 7 h after initial bacterial adhesion was sufficient to
eradicate all adhered P. aeruginosa cells at room temperature.(27) By contrast, PROLI/NO is
a water-soluble, small molecule diazeniumdiolate NO donor derived from the amino acid
proline. PROLI/NO releases a bolus of nitric oxide upon breakdown by water. Due to a short
half-life (t1/2 = 100 s), the majority of stored NO (10.4 ± 2.1 μmol NO mg−1) is released
within 300 s (Table 1). Standard plating experiments indicated a minimum bactericidal
concentration of 4 and 8 mg mL−1 PROLI/NO after 2 hours (MBC120) for E. coli and P.
aeruginosa, respectively (3-log reduction in cfu).
Nitric oxide release from the materials used in this study was measured in deoxygenated
PBS per the convention for measuring NO accurately via chemiluminescence. In contrast,
the experiments to evaluate the bactericidal effects of these materials were conducted in
normal PBS (i.e., not deoxygenated), since the bacteria are aerobic. Nevertheless, control
experiments indicated that the NO release from AHAP3/BTMOS xerogels in normal PBS
was indistinguishable from measurements made in deoxygenated PBS over 0 – 24 h, the
time frame of our experiments.
Due to the nature of diazeniumdiolate decomposition to NO (at physiological pH and
temperature), bacterial adhesion to NO-releasing xerogel films occurs concurrently with
exposure of the bacteria to a local NO flux. Although slower compared to control xerogels,
the surface coverage of P. aeruginosa to NO-releasing 40% AHAP3/BTMOS xerogels have
been shown to reach a steady state at 60 min under static conditions.(27) For these
experiments, NO-releasing surfaces were exposed to cell suspensions for 2 h, followed by
removal of loose cells and preparation of substrates for imaging (for 2 h time points) or
transfer of the substrates to PBS (for extended time points). To apply a similar approach for
treatment with antibiotic solutions (i.e., PROLI/NO and amoxicillin), bacteria were allowed
to adhere to control xerogel substrates for an hour prior to transfer of the cell-covered
substrate to a vial of antibiotic solution. Treating surface-adhered cells with antibacterial
agents provided the added benefits of capturing cell damage and debris locally on the
surface at the time of treatment while more nearly approximating an infection-causing
scenario.
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3.2 Morphologies of P. aeruginosa and E. coli adhered to control xerogels
Control 40% AHAP3/BTMOS xerogels have been reported to be non-toxic to bacteria
adhered at exposure periods > 24 h.(38) Thus, they represent a suitable substrate for the
study of normal morphologies, while providing a consistent sub-stratum for comparison of
healthy and antibiotic-treated (solution) cells to those treated via a surface flux of NO.
Representative images of untreated P. aeruginosa and E. coli cells adhered to control
xerogels are illustrated in Figure 2. P. aeruginosa cells are rod-shaped and exhibit regular
dimensions (~ 1 × 3 μm) with an inflated appearance and smooth cell exterior. Also rod-
shaped, E. coli are somewhat larger and more variable in length. On control surfaces, P.
aeruginosa adhered in well organized patterns that maximized contact along the long axis of
the cells while maintaining apparent structural integrity. By comparison, E. coli cells tended
to maintain some physical separation (i.e., adhering individually or in small groups of 2 to 3
cells). While P. aeruginosa are motile via flagella, E. coli have a characteristic crown of
fimbriae. Healthy cells of both species appeared intact with no visible pores, holes, grooves,
or breakages in the cell envelope. To negate any possible effect derived from the presence of
proline, E. coli and P. aeruginosa preadsorbed on control xerogels were incubated for 2 h
with 2 and 4 mg mL−1 proline, respectively. Physically, the proline exposed cells were
indistinguishable from untreated cells. Equivalent cell viability was verified by growing
colonies on nutrient agar.
3.3 Morphologies of NO-treated P. aeruginosa and E. coli
Sub-bactericidal concentrations such as those used in this study have historically been
applied to study antimicrobial effects as they provide ‘snapshots’ of the organism’s
morphology between healthy and dead states.(31,33,39) Figure 3 illustrates examples of P.
aeruginosa and E. coli bacteria after exposure to NO. A representative collection of images
was chosen to demonstrate the full spectrum of related morphologies resulting from NO
treatment. Many of the effects of NO exposure (e.g., membrane degradation) were exhibited
at multiple doses. A comprehensive list of the morphologies observed after treatment with
NO is included in Table 2. Many bullets are identical or similar for each species indicating
related mechanisms of action against both Gram-negative bacteria. Such features include
mild to extensive membrane degradation, debris present on the surface in the vicinity of
cells, blebbing or cellular parts abnormally attached to cells, cellular collapse, and lysis.
Spheroplast formation and increasingly short cellular length were more infrequent
morphologies common to both species, generally observed on xerogels after longer
exposures to surfaces fluxes of NO (6 – 8 h, Fig. 3D-E). Neither species exhibited
population arrangements on NO-releasing xerogels similar to those observed on controls. P.
aeruginosa adhered in a disorganized array, while E. coli cells abandoned their active
tendency to maintain spatial separation on a surface. Cells were occasionally observed to
adhere across a previously adhered cell, despite a low overall surface coverage.
The collection of morphologies observed indicates cell envelope damage as a visible and
significant contributing mechanism to the cytotoxic effect of NO against P. aeruginosa and
E. coli. The morphologies observed in this AFM study closely resemble those reported by
Li, et al. who concluded that their antibacterial peptides disrupted, permeabilized, and
eventually destroyed the stability of the outer and inner lipid membranes of P. aeruginosa
and E. coli.(33) The single morphology that points strictly to protein damage in this study,
the broken fimbriae frequently observed for E. coli, also occurred at the cell membrane.
Nitric oxide-mediated membrane damage has recently been reported by Hetrick, et al. using
confocal fluorescence microscopy.(28) In that study, P. aeruginosa membranes became
permeable to propidium iodide, a fluorescent dye that may only enter bacterial cells with
compromised membranes, after exposure to NO-releasing silica nanoparticles (maximum
NO flux ≈ 21700 ppb mg−1).
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Both delivery routes used in this study released NO exterior to, but in the vicinity of,
surface-adhered bacteria. As a broad-spectrum antibiotic, NO exerts both oxidative and
nitrosative stress on biomolecules at cell surfaces. Physically, NO and O2 are lipophilic and
membrane permeable leading to the concentration and sequestering of these molecules and
their reactive metabolites (e.g., N2O3) near lipid bilayers,(21) where membrane-bound and
other local proteins become targets of nitrosative stress. The formation of peroxynitrite from
the reaction of NO with intracellular O2− initiates the radical peroxidation of lipid
membranes (oxidative stress), potentially the cause of the observed degradation of these
structural components.
3.4 Analysis of membrane roughness after NO treatment
To further characterize the effect of NO on the Gram-negative cell, AFM images were
obtained of the bacterial membrane. The cell membrane damage by NO was readily
observed in representative three-dimensional reconstructions from height images after 2, 4,
6, and 8 h exposures to NO flux from xerogels (Figure 4). The range of the scales was held
constant (15 nm) to allow comparison between AFM images. Gram-negative cell envelopes
are composed of an outer and inner lipid membrane, each about 10 nm thick, separated by a
thin, cross-linked peptidoglycan layer. Holes in the outer lipid membrane began forming as
early as 2 h (Fig. 4B) after exposure to NO surface fluxes. Over time, the degree of
membrane degradation continued to increase, with large holes and crevices penetrating into
the inner membrane (Fig 4C-E). In fact, at exposure times exceeding 4 h the roughness of
the membrane exceeded the height scale. The image analysis software was then used to
apply light/shadow at identical angles and pitch to add a sense of depth. By comparison,
Figure 4A depicts the membrane of a healthy P. aeruginosa cell adhered to a control xerogel
for 24 h. Its morphological analysis confirms that changes in membrane roughness are a
function of NO-exposure and not surface residence time.
The quantitative rms roughness of cell membranes as a function of bacteria species and NO
exposure time/concentration is given in Table 3. As expected, longer exposure to a NO
surface flux (40% AHAP3/BTMOS xerogels) correlates with rougher cell membranes
ranging from ~1.6 nm for controls to nearly 4 and 12 nm after 8 h NO release for P.
aeruginosa and E. coli, respectively. Similarly, membrane roughness was greater for E. coli
for cells treated with greater concentrations of PROLI/NO (15.2 ± 4.6 and 28.9 ± 7.9 nm for
1 and 2 mg mL−1, respectively) (Fig. 5). Of note, the measured roughness for P. aeruginosa
was the same at both subbactericidal (MBC120 of PROLI/NO for P. aeruginosa is 8 mg
mL−1) concentrations of PROLI/NO (2 and 4 mg mL−1), and approximately double that
measured for the longest exposure to NO-releasing xerogels. If the deterioration of the lipid
bilayer leads to increased surface roughness, this may be indirect evidence that protein and/
or DNA damage contributes significantly to the cytotoxic effect of PROLI/NO against this
species.
3.5 Comparison of morphologies resulting from NO and amoxicillin treatment
Amoxicillin, a β-lactam antibiotic, functions by inhibiting enzymes that cross-link chains in
the peptidoglycan layer. Treatment of E. coli with a sub-bactericidal concentration of
amoxicillin was therefore expected to generate morphologies typical of cell wall
degradation. (P. aeruginosa was not treated with amoxicillin as it has demonstrated
resistance to the effects of this β-lactam.) The most common morphologies observed by
imaging amoxicillin-treated E. coli were perforations in the cell surface (pore formation) and
regions of collapsed cell wall, both concentrated (but not restricted to) the apical ends of the
cells (Fig. 6C, D). These observations are in agreement with a study that used AFM to
compare the morphological changes sustained by E. coli after treatment with amoxicillin and
its parent molecule, the natural product penicillin.(37) Both E. coli (Fig. 6A) and P.
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aeruginosa (Fig. 6B) exhibited analogous morphologies to the amoxicillin-treated cells when
treated with low levels of NO. In fact, these morphologies were only visualized on NO-
releasing xerogels at 2 h time points, and thus at the lowest concentrations of NO treatment
used in this study. At greater NO doses, these morphologies were obscured as the extent of
membrane damage increased and the incidence of localized effects decreased. Interestingly,
the morphologies observed for treatment of E. coli with penicillin, described by Yang, et al.
(37) as randomly distributed grooves and holes, strongly resemble the morphological
changes sustained by both E. coli and P. aeruginosa at greater NO doses. The similarity of
morphologies observed after treatment with amoxicillin, which functions by a known
mechanism of action, to those after exposure to NO offers additional support to the
conclusion that exposure to NO results in the deterioration of the cell envelope of Gram-
negative bacteria.
3.6 Comparison of NO delivery methods
Comparing NO-delivery methods proved less straightforward than varying exposure time or
concentration for a single delivery method. Both the NO-release kinetics (slow versus fast)
and manner of delivery (surface flux versus burst of NO release) differ for 40% AHAP3/
BTMOS xerogels and PROLI/NO. While treatment with PROLI/NO resulted in rougher,
more highly deteriorated cells than exposure to a sustained surface flux as visualized
qualitatively (Fig. 3) and measured quantitatively (Table 3), the total amount of NO released
as a bolus from sub-bactericidal concentrations of PROLI/NO exceeded that delivered by
sub-bactericidal fluxes of NO from 40% AHAP3/BTMOS. As the molecules of NO released
from PROLI/NO were dispersed throughout the solution rather than being concentrated at
the location of bacterial adhesion (i.e., at the surface), this may explain the significantly
greater quantities of NO necessary induce a bactericidal effect.
To deconvolute the efficacy of the delivery routes, P. aeruginosa cells were treated with a
bolus of NO slightly less than that delivered by a 40% AHAP3/BTMOS xerogel over 2 h.
Xerogel-adhered P. aeruginosa cells were immediately added to a 0.07 μM solution of NO
in 5 mL of PBS (prepared from a saturated NO solution) and incubated for 2 h under
conditions identical to the PROLI/NO experiments. The membrane roughness remained
greater when cells were treated by a bolus compared to surface flux from an NO-releasing
40% AHAP3/BTMOS xerogel (3.2 ± 0.6 nm vs. 2.1 ± 0.1 nm, respectively) (Table 3), and a
comparison of the P. aeruginosa membrane after treatment with an NO solution (Fig. 4F) to
that after 2 h exposure to surface flux (Fig. 4B) clearly demonstrates larger pores and
crevices in the former.
Bacterial species have evolved strategies to protect against the harmful effects of NO.(40)
For example, specific transcription factors (e.g., SoxR, OxyR) identified in E. coli are
capable of sensing NO released from macrophages and respond by up-regulating gene
expression to combat toxic effects.(41,42) Once detected in vivo, these proteins convert NO
to less toxic by-products such as nitrate.(43) Although the molecules of NO released from
PROLI/NO are dispersed throughout the medium, the total concentrations of NO and RNS
available to react with the adhered cells are greater during the initial period of incubation
when they are released via a bolus. Delivered in a highly concentrated burst, NO may
devastate bacterial cells before they are capable of mounting a defense. As an extension of
this hypothesis, future studies should investigate the behaviour of bacteria selected after
exposure to increasing concentrations of NO in an attempt to foster tolerance and probe the
upper limit of resistance to NO.
Conclusions—The morphologies of two Gram-negative species of bacteria were observed
using AFM after treatment with the antimicrobial agent NO. Quantitative measurements of
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surface roughness and qualitative observation of increased surface debris and changes in cell
shape (e.g., blebbing) and adhesion patterns indicate that membrane degradation is a
significant contributing factor to NO’s bacterial cytotoxicity. Comparison of morphological
effects perpetrated via a single, known mechanism (i.e., inhibition of cell wall synthesis by
amoxicillin) to those observed from treatment of NO aids in confirming the antimicrobial
mechanism of the latter. By evaluating NO sources with different NO-release kinetics, we
conclude that greater levels of NO released over short durations are more damaging to
Gram-negative bacteria than sustained, lower-level surface fluxes. The double lipid bilayer
of Gram-negative bateria typically acts as a permeability barrier to antibiotics that function
within the cell. Ironically, it is this same structural characteristic that renders these cells
particularly susceptible to NO-induced membrane damage. As degradation of the cell
envelope leads to an increase in permeability, treatment with NO may elicit synergistic
effects when used in concert with antibiotics.
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Nitric oxide released from a 40% AHAP3/BTMOS xerogel coating in PBS at 37 °C.
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Deflection images depict the morphology of healthy (A) P. aeruginosa; and (B) E. coli
bacteria.
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Three-dimensional reconstructions of height images illustrate P. aeruginosa and E. coli
morphologies, shown in the left and right columns, respectively. Parts (A-E) depict cells
treated by NO flux from 40% AHAP3/BTMOS xerogels for (A, C) 4 h; (B) 6 h; (D, E) 8 h.
Parts (F-J) show examples of bacteria treated with sub-bactericidal concentrations of
PROLI/NO for 2 h at (F-H) 1 mg mL−1; (I) 4 mg mL−1; and (J) 2 mg mL−1
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P. aeruginosa membranes on a control surface (A), and after exposure to NO surface flux for
(B) 2 h, (C) 4 h, (D) 6 h, and (E) 8 h from a 40% AHAP3/BTMOS xerogel, and (F) after
exposure to 0.07 μM NO in solution (bolus delivery).
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Three-dimensional reconstructions of E. coli membranes compare untreated (A) relative to
the degradation sustained after 6 h NO-release from a xerogel surface (B). Treatment with
sub-bactericidal PROLI/NO concentrations of 1 mg mL−1 (C) and 2 mg mL−1 (D) show
more extensive damage only 2 h after exposure. Note the difference in scale range.
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Comparison of the morphological effects caused by treatment with NO on E. coli (A) and P.
aeruginosa (B) strongly resemble the morphologies demonstrated by E. coli after treatment
with amoxicillin (C), a β-lactamase that inhibits cell wall synthesis. Furthermore, the three-
dimensional rendering of the compromised cell wall (D) after treatment with amoxicillin
resembles the holes and crevices exhibited by P. aeruginosa and E. coli after NO treatment,
indicative of membrane damage.
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Table 1
Measured NO released from antibacterial materials
material NO delivery exposure dose NO
b
xerogel surface flux 2 h 1.32 ±0.13 (μmol cm−2)
4 h 1.93 ±0.19
6 h 2.39 ± 0.23
8 h 2.70 ± 0.27
PROLI/NO bolus 70 s 3.4 ± 1.1 (μmol mg−1)
300 s
a 8.8 ± 2.0
a
The majority of NO has been released after this time. The total NO released by 1 mg of PROLI/NO is 10.4 ± 2.1 μmol NO.
b
Average dose of NO reported with standard deviation
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Table 2
Morphologies exhibited by Gram-negative bacteria after NO treatment
P. aeruginosa E. coli
■ Cellular debris




• Increased surface roughness
• Layered appearance
• Pores and crevices easily visualized
■ Cell collapse
• Lower height (< ~30 nm)
• Flatter appearance
• Some internal structures visible
■ Cell lysis





• Granule-like particles near cell
• Occasionally cell-associated
■ Membrane degradation
• Large increases in surface roughness
• Bumps and crevices in cell surface
■ Cell collapse
■ Cell lysis
■ Decreased height and length
■ Spheroplast formation
■ Damage at apical ends and along sides of cell
• Frequent collapse of apical ends
• Collapse of specific regions of the cell
○ Usually along edge of cell
○ Occasionally in cell interior
■ Broken fimbriae
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Table 3
Root-mean-square (rms) roughness of cell membranes
Species material exposure average (nm)
a
P. aeruginosa xerogel control 1.61 ±0.27
2 h 2.13 ±0.09
4 h 2.25 ±0.30
6 h 3.20 ± 0.31
8 h 3.84 ± 0.76
PROLI/NO 2 mg mL−1 7.15 ±1.52
4 mg mL−1 7.10 ±0.86
NO solution 0.07 μM 3.16 ±0.61
E. coli xerogel control 1.55 ±0.21
2 h 2.66 ± 0.66
4 h 3.24 ± 0.45
6 h 4.33 ± 0.55
8h 11.7 ± 1.9
PROLI/NO 1 mg mL−1 15.2 ±4.6
2 mg mL−1 28.9 ± 7.9
a
Average rms roughness reported with standard deviation
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